Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
Medicine name | tobramycin (Bramitob®) |
Formulation | 300 mg/4 ml nebuliser solution |
Reference number | 54 |
Indication | Management of chronic pulmonary infection due to pseudomonas aeruginosa in patients with cystic fibrosis aged 6 and older |
Company | Chiesi Ltd |
BNF chapter | Infections |
Submission type | N/A |
Status | Medicine does not meet criteria for AWMSG assessment |
Date of issue | 04/08/2009 |